Majka Serafini

Majka Serafini is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as the Global Leader of Immuno-Oncology Early Assets at Boehringer Ingelheim since April 2022. Prior experience includes European Director at Daiichi Sankyo Europe GmbH from 2019 to April 2022, Head of Franchise Marketing at Roche from 2015 to 2018, and Brand Leader in Oncology at Sanofi from 2014 to 2015. Between 2009 and 2014, Majka held roles in Brand and Sales Management focused on Oncology and Rare Diseases at Novartis, and earlier experience at Eli Lilly and Company included positions in Brand Management and Specialist Sales. Prior to entering the pharmaceutical sector, Majka worked as a Business Analyst & Marketing professional at Ericsson North America from December 2000 to April 2005. Educational qualifications include degrees from Virginia Tech - Pamplin College of Business, MIB Trieste School of Management, Stanford University, and a certificate in Medicine from Harvard Medical School obtained in May 2023.